LAUSR

ABSTRACT The urgent need for more effective analgesic treatment options has prompted a re‐evaluation of the behavioral tests used to assess pain in pre‐clinical research, with an emphasis on inclusion of more voluntary, un‐evoked behavioral assessments of pain. In order to validate voluntary gait analysis and a voluntary mechanical conflict‐avoidance assay, we tested mouse models of neuropathy (spared nerve injury) and inflammation (complete Freund's adjuvant) alongside reflexive measures of mechanical and thermal hypersensitivity. To establish whether the observed changes in behavioral responses were pain‐related, known analgesics (buprenorphine, gabapentin, carprofen) were also administered. Spared nerve injury persistently altered several gait indices, whereas complete Freund's adjuvant caused only transient changes. Furthermore, known analgesics could not reverse these gait changes, despite demonstrating their previously established efficacy in reflexive measures of mechanical and thermal hypersensitivity. In contrast, the mechanical conflict‐avoidance assay demonstrated aversion in mice with neuropathy and inflammation‐induced hypersensitivity, which could both be reversed by analgesics. We conclude that voluntary gait changes in rodent neuropathic and inflammatory pain models are not necessarily indicative of pain‐related adaptations. On the other hand, mechanical conflict‐avoidance represents a valid operant assay for quantifying pain‐related behaviors in mice that can be reversed by known analgesics. HIGHLIGHTSA neuropathic pain model causes prolonged changes in mouse voluntary gait patterns.An inflammatory pain model causes relatively transient gait changes.Gait changes induced by neuropathy/inflammation are not reversible with analgesics.A mechanical conflict‐avoidance (MCA) test detects changes in these pain models.Neuropathy/inflammation‐induced changes in MCA behavior are reversed by analgesics.